Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (803)	6/10/2003 3:14:49 PM
From: Jibacoa	Read Replies (1) of 1005

More news keep coming,from INGN, but hasn't helped the stock today on account of the profit taking.<g> Acording to the report: "The study showed that MDA-7 protein was 20-50 fold more potent in anti-angiogenic experiments than endostatin." "In vivo studies demonstrated anti-angiogenic activity of MDA-7 in animals -- this activity resulted in inhibition of growth of lung tumors". biz.yahoo.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next